Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.80% Nasdaq Up0.97%

Theravance Inc. (THRX)

-NasdaqGS

39.58 May 17, 4:00PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 30, 2013Dec 30, 2012Sep 29, 2012Jun 29, 2012
Total Revenue 1,344   5,798   1,431   1,430  
Cost of Revenue -   -   -   -  
Gross Profit 1,344   5,798   1,431   1,430  
Operating Expenses
Research Development26,416  28,120  27,027  29,549  
Selling General and Administrative8,315  7,658  7,754  7,590  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (33,387) (29,980) (33,350) (35,709)
Income from Continuing Operations
Total Other Income/Expenses Net(1,237)156  159  89  
Earnings Before Interest And Taxes(34,624)(29,824)(33,191)(35,620)
Interest Expense2,736  1,500  1,501  1,500  
Income Before Tax(37,360)(31,324)(34,692)(37,120)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(37,360)(31,324)(34,692)(37,120)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (37,360) (31,324) (34,692) (37,120)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (37,360) (31,324) (34,692) (37,120)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.